| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.99B | 13.83B | 11.37B | 7.44B | 7.45B | 16.85B |
| Gross Profit | 13.12B | 11.90B | 10.93B | 7.01B | 7.13B | 16.65B |
| EBITDA | 7.37B | 7.21B | 6.50B | 3.00B | 3.53B | 13.63B |
| Net Income | 3.05B | 3.02B | 2.78B | 1.39B | 1.75B | 5.86B |
Balance Sheet | ||||||
| Total Assets | 48.33B | 47.71B | 43.47B | 40.29B | 42.52B | 41.20B |
| Cash, Cash Equivalents and Short-Term Investments | 2.45B | 2.63B | 1.97B | 2.96B | 4.25B | 2.12B |
| Total Debt | 14.16B | 13.31B | 12.29B | 12.29B | 13.37B | 8.71B |
| Total Liabilities | 26.91B | 25.83B | 23.97B | 22.21B | 22.84B | 19.49B |
| Stockholders Equity | 8.37B | 8.67B | 8.21B | 6.82B | 7.66B | 9.42B |
Cash Flow | ||||||
| Free Cash Flow | 3.35B | 1.74B | 3.42B | 3.83B | 6.10B | 3.92B |
| Operating Cash Flow | 3.47B | 1.86B | 3.48B | 4.06B | 6.34B | 3.99B |
| Investing Cash Flow | 1.14B | 5.28B | -61.41M | -229.65M | -235.50M | -64.32M |
| Financing Cash Flow | -5.30B | -6.40B | -4.50B | -5.05B | -3.79B | -3.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $176.18B | 16.88 | 11.52% | 1.92% | 22.84% | -3.04% | |
70 Outperform | $144.00B | 34.66 | 36.16% | 3.02% | 17.79% | 17.92% | |
69 Neutral | $40.71B | 42.85 | 14.54% | 2.65% | 46.89% | 21.89% | |
68 Neutral | $16.06B | -1,111.90 | 12.56% | 3.03% | 11.60% | 28307.69% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $87.07B | 50.85 | 9.92% | 0.56% | 35.81% | 27.22% | |
58 Neutral | $17.29B | -32.87 | 9.65% | 2.30% | -26.37% | -49.86% |